Swiss Life Private Equity Partners logo

Swiss Life Private Equity Partners

Europe, Zurich, Switzerland, Zürich

Description

Swiss Life Private Equity Partners specializes in asset management and investment consulting in the private equity sector.

Investor Profile

Swiss Life Private Equity Partners has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (33%)
  • Series Unknown (17%)
  • Secondary Market (17%)
  • Series A (17%)
  • Series B (17%)

Country Focus

  • United States (67%)
  • Germany (17%)
  • Switzerland (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Manufacturing
  • Optical Communication
  • Private Social Networking
  • Consulting
  • Information Technology
  • Risk Management
  • Developer Platform
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Swiss Life Private Equity Partners frequently co-invest with?

NIBC Bank N.V.
Europe, Zuid-Holland, The Netherlands, The Hague
Co-Investments: 1
Boston Millennia Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
Bioventures Investors
North America, Massachusetts, United States, Wellesley
Co-Investments: 1
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 1
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
BC
North America, California, United States, San Mateo
Co-Investments: 1
Techno Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Yasuda Enterprise Development
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Co-Investments: 1
Bank of America Securities
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Swiss Life Private Equity Partners?

DataBank

Dallas, Texas, United States

DataBank is an information management and security company offering customized technology solutions to businesses.

ConsultingInformation TechnologyRisk Management
Secondary MarketAug 30, 2022
Amount Raised: $1,500,000,000
Phenex Pharmaceuticals

Heidelberg, Baden-Wurttemberg, Germany

Phenex Pharmaceuticals is a drug discovery and development company focused on developing novel pharmaceuticals.

BiopharmaBiotechnologyPharmaceutical
Series CSep 21, 2010
Amount Raised: $7,912,790
Enanta Pharmaceuticals

Watertown, Massachusetts, United States

Enanta Pharmaceuticals is an R&D company discovers, develops and promotes of small molecule drugs in the areas of anti-infective.

BiotechnologyHealth CarePharmaceutical
Series UnknownJan 14, 2004
Amount Raised: $12,000,000
iolon, inc.

San Jose, California, United States

A privately held optical networking components company.

ManufacturingOptical CommunicationPrivate Social Networking
Series CApr 25, 2002
Amount Raised: $7,600,000
Zeptosens

Wilderswil, Bern, Switzerland

Zeptosens is an ultra-sensitive microarray platform for quantitative proteomic investigations.

BiotechnologyHealth CareMedical
Series BFeb 27, 2001
Amount Raised: $8,339,643
Acorda Therapeutics

Hawthorne, New York, United States

Acorda Therapeutics began in 1995 as a network of scientists, physicians and business people with a common belief.

BiotechnologyDeveloper PlatformHealth Care
Series AJan 8, 2001
Amount Raised: $33,700,000